Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Human catechol O-methyltransferase genetic variation: gene resequencing and functional characterization of variant allozymes

Molecular Psychiatry volume 9, pages 151–160 (2004)Cite this article

Abstract

Catechol O-methyltransferase (COMT) plays an important role in the metabolism of catecholamines, catecholestrogens and catechol drugs. A common COMT G472A genetic polymorphism (Val108/158Met) that was identified previously is associated with decreased levels of enzyme activity and has been implicated as a possible risk factor for neuropsychiatric disease. We set out to ‘resequence’ the human COMT gene using DNA samples from 60 African-American and 60 Caucasian-American subjects. A total of 23 single nucleotide polymorphisms (SNPs), including a novel nonsynonymous cSNP present only in DNA from African-American subjects, and one insertion/deletion were observed. The wild type (WT) and two variant allozymes, Thr52 and Met108, were transiently expressed in COS-1 and HEK293 cells. There was no significant change in level of COMT activity for the Thr52 variant allozyme, but there was a 40% decrease in the level of activity in cells transfected with the Met108 construct. Apparent Km values of the WT and variant allozymes for the two reaction cosubstrates differed slightly, but significantly, for 3,4-dihydroxybenzoic acid but not for S-adenosyl-L-methionine. The Met108 allozyme displayed a 70–90% decrease in immunoreactive protein when compared with WT, but there was no significant change in the level of immunoreactive protein for Thr52. A significant decrease in the level of immunoreactive protein was also observed in hepatic biopsy samples from patients homozygous for the allele encoding Met108. These observations represent steps toward an understanding of molecular genetic mechanisms responsible for variation in COMT level and/or properties, variation that may contribute to the pathophysiology of neuropsychiatric disease.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

References

  1. Axelrod J, Tomchick R . Enzymatic O-methylation of epinephrine and other catechols. J Biol Chem 1958; 233: 702–705.

    CAS  PubMed  Google Scholar 

  2. Guldberg HC, Marsden CA . Catechol-O-methyltransferase: pharmacological aspects and physiological role. Pharmacol Rev 1975; 27: 135–206.

    CAS  PubMed  Google Scholar 

  3. Roth JA . Membrane-bound catechol O-methyltransferase: a reevaluation of its role in the O-methylation of the catecholamine neurotransmitter. Rev Physiol Biochem Pharmacol 1992; 120: 1–29.

    Article  CAS  PubMed  Google Scholar 

  4. Tenhunen J, Salminen M, Lundstrom K, Kiviluoto T, Savolainen R, Ulmanen I . Genomic organization of the human catechol-O-methyltransferase gene and its expression from two distinct promoters. Eur J Biochem 1994; 223: 1049–1059.

    Article  CAS  PubMed  Google Scholar 

  5. Weinshilboum RM, Raymond FA . Inheritance of low erythrocyte catechol-O-methyltransferase activity in man. Am J Hum Genet 1977; 29: 125–135.

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Spielman RS, Weinshilboum RM . Family studies of low red cell COMT activity. Am J Hum Genet 1979; 31: 63A.

    Google Scholar 

  7. Floderus Y, Wetterberg L . The inheritance of human erythrocyte catechol-O-methyltransferase activity. Clin Genet 1981; 19: 392–395.

    Article  CAS  PubMed  Google Scholar 

  8. Siervogel RM, Weinshilboum R, Wilson AF, Elston RC . Major gene model for the inheritance of catechol-O-methyltransferase activity in five large families. Am J Med Genet 1984; 19: 315–323.

    Article  CAS  PubMed  Google Scholar 

  9. Weinshilboum RM . Human erythrocyte catechol-O-methyltransferase: correlation with lung and kidney activity. Life Sci 1978; 22: 625–630.

    Article  CAS  PubMed  Google Scholar 

  10. Boudíková B, Szumlanski C, Maidak B, Weinshilboum R . Catechol O-methyltransferase (COMT) pharmacogenetics. Clin Pharmacol Ther 1990; 48: 381–389.

    Article  PubMed  Google Scholar 

  11. Scanlon PD, Raymond FA, Weinshilboum RM . Catechol-O-methyltransferase: thermolabile enzyme in erythrocytes of subjects homozygous for the allele for low activity. Science 1979; 203: 63–65.

    Article  CAS  PubMed  Google Scholar 

  12. Spielman RS, Weinshilboum RM . Genetics of red cell COMT activity: analysis of thermal stability and family data. Am J Med Genet 1981; 10: 279–290.

    Article  CAS  PubMed  Google Scholar 

  13. Bertocci B, Miggiano V, Da Prada M, Dembic Z, Lahm H-W, Malherbe P . Human catechol O-methyltransferase: cloning and expression of membrane-associated form. Proc Natl Acad Sci USA 1991; 88: 1416–1420.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Lundström K, Salminen M, Jalanko A, Savolainen R, Ulmanen I . Cloning and characterization of human placental catechol-O-methyltransferase cDNA. DNA Cell Biol 1991; 10: 181–189.

    Article  PubMed  Google Scholar 

  15. Grossman MH, Emanuel BS, Budaf ML . Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1–q11.2. Genomics 1992; 12: 822–825.

    Article  CAS  PubMed  Google Scholar 

  16. Lachman HM, Papolos DF, Saito T, Yu Y-M, Szumlanski CL, Weinshilboum RM . Human catechol O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996; 6: 243–250.

    Article  CAS  PubMed  Google Scholar 

  17. Ameyaw M, Syvanen A, Ulmanen I, Ofori-Adjei D, McLeod HL . Pharmacogenetics of catechol-O-methyltransferase: frequency of low activity allele in a Ghanaian population. Hum Mutat 2000; 16: 445–446.

    Article  CAS  PubMed  Google Scholar 

  18. Palmatier MA, Kang AM, Kidd KK . Global variation in the frequencies of functionally different catechol O-methyltransferase alleles. Biol Psychiatry 1999; 46: 557–567.

    Article  CAS  PubMed  Google Scholar 

  19. Strous RD, Bark N, Parsia SS, Volavka J, Lachman HM . Analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association with aggressive and antisocial behavior. Psychiatr Res 1997; 69: 71–77.

    Article  CAS  Google Scholar 

  20. Karayiorgou M, Altemus M, Galke BL, Goldman D, Murphy DL, Ott J et al. Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive–compulsive disorder. Proc Natl Acad Sci USA 1997; 94: 4572–4575.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Mynett-Johnson LA, Murphy VE, Claffey E, Shields DC, McKeon P . Preliminary evidence of an association between bipolar disorder in females and the catechol-O-methyltransferase gene. Psychiatr Genet 1998; 8: 221–225.

    Article  CAS  PubMed  Google Scholar 

  22. Kunugi H, Nanko S, Ueki A, Otsuka E, Hattori M, Hoda F et al. High and low activity alleles of catechol O-methyltransferase gene: ethnic difference and possible association with Parkinson's disease. Neurosci Lett 1997; 221: 202–204.

    Article  CAS  PubMed  Google Scholar 

  23. Lavigne JA, Helzlsouer KJ, Huang H-Y, Strickland PT, Bell DA, Selmin O et al. An association between the allele coding for a low activity variant of catechol O-methyltransferase and the risk for breast cancer. Cancer Res 1997; 57: 5493–5497.

    CAS  PubMed  Google Scholar 

  24. Craddock N, Dave S, Greening J . Association studies of bipolar disorder. Bipolar Disord 2001; 3: 284–298.

    Article  CAS  PubMed  Google Scholar 

  25. Schindler KM, Richter MA, Kennedy JL, Pato MT, Pato CN . Association between homozygosity at the COMT gene locus and obsessive compulsive disorder. Am J Med Genet 2000; 96: 721–724.

    Article  CAS  PubMed  Google Scholar 

  26. Mizuta I, Mizuta E, Yamasaki S, Kuno S, Yasuda M, Tanaka C . Meta-analysis of polymorphism of the catechol-O-methyltransferase gene in relation to the etiology of Parkinson's disease in Japan. Movement Disord 2000; 15: 1013–1014.

    Article  CAS  PubMed  Google Scholar 

  27. Holden C . Deconstructing schizophrenia. Science 2003; 299: 333–335.

    Article  CAS  PubMed  Google Scholar 

  28. Chadwick RB, Conrad MP, McGinnis MD, Johnston-Dow L, Spurgeon SL, Kronick MN . Heterozygote and mutation detection by direct automated fluorescent DNA sequencing using a mutant Taq DNA polymerase. BioTechniques 1996; 20: 676–683.

    CAS  PubMed  Google Scholar 

  29. Nickerson DA, Tobe VO, Taylor SL . PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res 1997; 25: 2745–2751.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Gordon D, Abajian C, Green P . Consed: a graphical tool for sequence finishing. Genome Res 1998; 8: 195–202.

    Article  CAS  PubMed  Google Scholar 

  31. Devereux J, Haeberli P, Smithies O . A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res 1984; 12: 387–395.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR . Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 1989; 77: 51–59.

    Article  CAS  PubMed  Google Scholar 

  33. Wood TC, Aksoy IA, Aksoy S, Weinshilboum RM . Human liver thermolabile phenol sulfotransferase: cDNA cloning, expression and characterization. Biochem Biophys Res Commun 1994; 198: 1119–1127.

    Article  CAS  PubMed  Google Scholar 

  34. Raymond FA, Weinshilboum RM . Microassay of human erythrocyte catechol-O-methyltransferase: removal of inhibitory calcium ion with chelating resin. Clin Chim Acta 1975; 58: 185–194.

    Article  CAS  PubMed  Google Scholar 

  35. Bradford MM . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein–dye binding. Anal Biochem 1976; 72: 248–254.

    Article  CAS  PubMed  Google Scholar 

  36. Wilkinson GN . Statistical estimations in enzyme kinetics. Biochem J 1961; 80: 324–332.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Cleland WW . Computer programmes for processing enzyme kinetic data. Nature 1963; 198: 463–465.

    Article  CAS  PubMed  Google Scholar 

  38. Hartl DL, Clark AG . Principles of Population Genetics, 2nd edn. Sinauer Associates, Inc.: Sunderland, MA, 1989.

    Google Scholar 

  39. Hendrick PW . Genetics of Populations, 2nd edn. Jones and Bartlett Publ.: Sudbury, MA, 2000, pp 396–405.

    Google Scholar 

  40. Long JC, Williams RC, Urbanek M . An E-M algorithm and testing strategy for multiple-locus haplotypes. Am J Hum Genet 1995; 56: 799–810.

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Excoffier L, Slatkin M . Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995; 12: 921–927.

    CAS  PubMed  Google Scholar 

  42. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA . Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002; 70: 425–434.

    Article  PubMed  Google Scholar 

  43. Schneider S, Roessli D, Excofier L . Arlequin: a software for population genetics data analysis, Version 2.000. Genetics and Biometry Lab, Department of Anthropology, University of Geneva, 2000.

  44. McLeod HL, Fang L, Luo X, Scott EP, Evans WE . Ethnic differences in erythrocyte catechol O-methyltransferase activity in black and white Americans. J Pharmacol Exp Ther 1994; 270: 26–29.

    CAS  PubMed  Google Scholar 

  45. Vidgren J, Svensson LA, Liljas A . Crystal structure of catechol O-methyltransferase. Nature 1994; 368: 354–358.

    Article  CAS  PubMed  Google Scholar 

  46. Ingrosso D, Fowler AV, Bleibaum J, Clarke S . Sequence of the D-aspartyl/L-isoaspartyl protein methyltransferase from human erythrocytes: common sequence motifs for protein, DNA, RNA and small molecule S-adenosylmethionine-dependent methyltransferases. J Biol Chem 1989; 264: 20131–20139.

    CAS  PubMed  Google Scholar 

  47. Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 1999; 22: 231–238.

    Article  CAS  PubMed  Google Scholar 

  48. Saito S, Iida A, Sekine A, Miura Y, Sakamoto T, Ogawa C et al. Identification of 197 genetic variations in six human methyltransferase genes in the Japanese population. J Hum Genet 2001; 46: 529–537.

    Article  CAS  PubMed  Google Scholar 

  49. Xie T, Ho SL, Ramsden D . Characterization and implications of estrogenic down-regulation of human catechol O-methyltransferase gene transcription. Mol Pharmacol 1999; 56: 31–38.

    Article  CAS  PubMed  Google Scholar 

  50. Wingender E, Chen X, Hehl R, Karas H, Liebich I, Matys V et al. TRANSFAC: an integrated system for gene expression regulation. Nucleic Acids Res 2000; 28: 316–319.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Halushka MK, Fan J-B, Bentley K, Hsie L, Shen N, Weder A et al. Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nat Genet 1999; 22: 239–247.

    Article  CAS  PubMed  Google Scholar 

  52. Stephens JC, Schneider JA, Tanguay DA, Choi J, Acharya T, Stanley SE et al. Haplotype variation and linkage disquilibrium in 313 human genes. Science 2001; 293: 489–493.

    Article  CAS  PubMed  Google Scholar 

  53. Fullerton SM, Clark AG, Weiss KM, Nickerson DA, Taylor SL, Stengard JH et al. Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism. Am J Hum Genet 2000; 67: 881–900.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Freimuth RR, Eckloff B, Wieben ED, Weinshilboum RM . Human sulfotransferase SULT1C1 pharmacogenetics: gene resequencing and functional genomic studies. Pharmacogenetics 2001; 11: 747–756.

    Article  CAS  PubMed  Google Scholar 

  55. Thomae BA, Eckloff BW, Freimuth RR, Wieben ED, Weinshilboum RM . Human sulfotransferase SULT2A1 pharmacogenetics: genotype-to-phenotype studies. Pharmacogenomics J 2002; 2: 48–56.

    Article  CAS  PubMed  Google Scholar 

  56. Xu Z-H, Freimuth RR, Eckloff B, Wieben E, Weinshilboum RM . Human 3′-phosphoadenosine 5′-phosphosulfate synthetase 2 (PAPSS2) pharmacogenetics: gene resequencing, genetic polymorphisms and functional characterization of variant allozymes. Pharmacogenetics 2002; 12: 11–21.

    Article  CAS  PubMed  Google Scholar 

  57. Preuss CV, Wood TC, Szumlanski CL, Raftogianis RB, Otterness DM, Girard B et al. Human histamine N-methyltransferase pharmacogenetics: common genetic polymorphisms that alter activity. Mol Pharmacol 1998; 53: 708–717.

    Article  CAS  PubMed  Google Scholar 

  58. Szumlanski C, Otterness D, Her C, Lee D, Brandriff B, Kelsell D et al. Thiopurine methyltransferase pharmacogenetics: human gene cloning and characterization of a common polymorphism. DNA Cell Biol 1996; 15: 17–30.

    Article  CAS  PubMed  Google Scholar 

  59. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, Julkunen I et al. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 1995; 34: 4202–4210.

    Article  CAS  PubMed  Google Scholar 

  60. Klemetsdal B, Staume B, Giverhaug T, Aarbakke J . Low catechol-O-methyltransferase activity in a Saami population. Eur J Clin Pharmacol 1994; 46: 231–235.

    Article  CAS  PubMed  Google Scholar 

  61. Goodman JE, Jensen LT, He P, Yager JD . Characterization of human soluble high and low activity catechol-O-methyltransferase catalyzed catechol estrogen methylation. Pharmacogenetics 2002; 12: 517–528.

    Article  CAS  PubMed  Google Scholar 

  62. Tai H-L, Fessing MY, Bonten EJ, Yanishevsky Y, d'Azzo A, Krynetski EY et al. Enhanced proteasomal degradation of mutant human thiopurine S-methyltransferase (TPMT) in mammalian cells: mechanism for TPMT protein deficiency inherited by TPMT*2, TPMT*3A, TPMT*3B or TPMT*3C. Pharmacogenetics 1999; 9: 641–650.

    Article  CAS  PubMed  Google Scholar 

  63. Siegel D, Anwar A, Winski SL, Kepa JK, Zolman KL, Ross D . Rapid polyubiquitination and proteosomal degradation of a mutant form of NAD(P)H:quinone oxioreductase 1. Mol Pharmacol 2001; 59: 263–268.

    Article  CAS  PubMed  Google Scholar 

  64. Wang L, Sullivan W, Toft D, Weinshilboum R . Thiopurine S-methyltransferase (TPMT) pharmacogenetics: role of chaperone proteins in variant allozyme degradation. Clin Pharmacol Ther 2003; 73: P29.

    Article  Google Scholar 

  65. Beutler E, Gelbart T, Demina A . Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci USA 1998; 95: 8170–8174.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank Dr Daniel Schaid for performing the linkage and haplotype analyses and Ms Luanne Wussow for her assistance with the preparation of this manuscript. This work was supported in part by NIH Grants RO1 GM28157 (RMW), RO1 GM35720 (RMW), PO1 CA82267 (RWM), UO1 GM61388 (RMW and EDW) and R25T CA92049 (AJS).

Author information

Authors and Affiliations

  1. Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Medical School, Mayo Clinic, Mayo Foundation, Rochester, MN, USA

    A J Shield, B A Thomae & R M Weinshilboum

  2. Department of Biochemistry and Molecular Biology, Mayo Medical School, Mayo Clinic, Mayo Foundation, Rochester, MN, USA

    B W Eckloff & E D Wieben

Authors
  1. A J Shield
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B A Thomae
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B W Eckloff
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E D Wieben
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R M Weinshilboum
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R M Weinshilboum.

Additional information

The DNA resequencing data described in this manuscript have been deposited in the NIH-sponsored Pharmacogenetics Research Network database PharmGKB with Accession Number PA117.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Shield, A., Thomae, B., Eckloff, B. et al. Human catechol O-methyltransferase genetic variation: gene resequencing and functional characterization of variant allozymes. Mol Psychiatry 9, 151–160 (2004). https://doi.org/10.1038/sj.mp.4001386

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.mp.4001386

Keywords

  • catechol O-methyltransferase
  • COMT
  • methylation
  • genetic polymorphisms
  • SNPs
  • pharmacogenetics

This article is cited by

Search

Advanced search

Quick links